Identification of a two-loci epistatic interaction associated with susceptibility to rheumatoid arthritis through reverse engineering and multifactor dimensionality reduction

被引:29
作者
Julia, Antonio
Moore, Jason
Miquel, Laia
Alegre, Cayetano
Ritchie, Marylyn
Marsal, Sara [1 ]
机构
[1] Hosp Univ Vall Hebron, Inst Recerca, Unitat Recerca Reumatol, Barcelona 08035, Spain
[2] Dartmouth Coll, Hitchcock Med Ctr, Computat Genet Lab, Lebanon, NH 03756 USA
[3] Univ Autonoma Barcelona, Dept Biol & Bioquim Mol, E-08193 Barcelona, Spain
[4] Hosp Gen Univ Vall Hebron, Unitat Reumatol, Barcelona 08035, Spain
[5] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37240 USA
关键词
rheumatoid arthritis; synovial membrane; fibroblast; DNA microarrays; bioinformatics; transcription factor; promoter; SNPs; genetic epistasis; genetic susceptibility;
D O I
10.1016/j.ygeno.2007.03.011
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Altered synovial fibroblast (SF) transcriptional activity is a key factor in the disease progression of rheumatoid arthritis (RA). To determine the transcriptional regulatory network associated with SF response to an RA proinflammatory stimulus we applied a CARRIE reverse engineering approach to microarray gene expression data from SFs treated with RA synovial fluid. The association of the inferred gene network with RA susceptibility was further analyzed by a case-control study of promoter single-nucleotide polymorphisms, and the presence of epistatic interactions was determined using the multifactor dimensionality reduction methodology. Our findings suggest that a specific NF-kappa B transcriptional regulatory network of 13 genes is associated with SF response to RA proinflammatory stimulus and identify a significant epistatic association of two of its genes, IL6 and IL4II, with RA susceptibility. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:6 / 13
页数:8
相关论文
共 50 条
[1]   Direct evidence of high DNA binding activity of transcription factor AP-1 in rheumatoid arthritis synovium [J].
Asahara, H ;
Fujisawa, K ;
Kobata, T ;
Hasunuma, T ;
Maeda, T ;
Asanuma, M ;
Ogawa, N ;
Inoue, H ;
Sumida, T ;
Nishioka, K .
ARTHRITIS AND RHEUMATISM, 1997, 40 (05) :912-918
[2]   NF-κB regulation by IκB kinase-2 in rheumatoid arthritis synoviocytes [J].
Aupperle, KR ;
Bennett, BL ;
Han, ZN ;
Boyle, DL ;
Manning, AM ;
Firestein, GS .
JOURNAL OF IMMUNOLOGY, 2001, 166 (04) :2705-2711
[3]   Reverse engineering of regulatory networks in human B cells [J].
Basso, K ;
Margolin, AA ;
Stolovitzky, G ;
Klein, U ;
Dalla-Favera, R ;
Califano, A .
NATURE GENETICS, 2005, 37 (04) :382-390
[4]  
BETTS JC, 1993, J BIOL CHEM, V268, P25624
[5]   The non-MHC quantitative trait locus Cia5 contains three major arthritis genes that differentially regulate disease severity, pannus formation, and joint damage in collagen-and pristane-induced arthritis [J].
Brenner, M ;
Meng, HC ;
Yarlett, NC ;
Joe, B ;
Griffiths, MM ;
Remmers, EF ;
Wilder, RL ;
Gulko, PS .
JOURNAL OF IMMUNOLOGY, 2005, 174 (12) :7894-7903
[6]   Multifactor-dimensionality reduction shows a two-locus interaction associated with Type 2 diabetes mellitus [J].
Cho, YM ;
Ritchie, MD ;
Moore, JH ;
Park, JY ;
Lee, KU ;
Shin, HD ;
Lee, HK ;
Park, KS .
DIABETOLOGIA, 2004, 47 (03) :549-554
[7]   Interleukin 4-induced gene 1 is activated in primary mediastinal large B-cell lymphoma [J].
Copie-Bergman, C ;
Boulland, ML ;
Dehoulle, C ;
Möller, P ;
Farcet, JP ;
Dyer, MJS ;
Haioun, C ;
Roméo, PH ;
Gaulard, P ;
Leroy, K .
BLOOD, 2003, 101 (07) :2756-2761
[8]   A question of transformation - The synovial fibroblast in rheumatoid arthritis [J].
Davis, LS .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (05) :1399-1402
[9]   Two novel IL-1 family members, IL-1δ and IL-1ε, function as an antagonist and agonist of NF-κB activation through the orphan IL-1 receptor-related protein 2 [J].
Debets, R ;
Timans, JC ;
Homey, B ;
Zurawski, S ;
Sana, TR ;
Lo, S ;
Wagner, J ;
Edwards, G ;
Clifford, T ;
Menon, S ;
Bazan, JF ;
Kastelein, RA .
JOURNAL OF IMMUNOLOGY, 2001, 167 (03) :1440-1446
[10]   REQUIREMENT FOR NUCLEAR FACTOR (NF)-KAPPA-B P65 AND NF-INTERLEUKIN-6 BINDING-ELEMENTS IN THE TUMOR-NECROSIS-FACTOR RESPONSE REGION OF THE GRANULOCYTE-COLONY-STIMULATING FACTOR PROMOTER [J].
DUNN, SM ;
COLES, LS ;
LANG, RK ;
GERONDAKIS, S ;
VADAS, MA ;
SHANNON, MF .
BLOOD, 1994, 83 (09) :2469-2479